Abstract: A system to assist users with the completion of tasks in a wellness program itinerary. The system assists users in completing tasks by recommending a controlled number of tasks for a user to perform in a next task period. The system determines the number of tasks to recommend by computing a pace that would enable the user to complete all wellness programs in the itinerary within a recommended time period. The system determines which tasks to recommend to the user based on several factors, such as a user state and user environment. The user environment is based on the location of the user, and may include the weather and surrounding landmarks at the location.

Abstract: A wellness intervention system that collects data about multiple factors pertaining to an individual's health and uses such data to generate timely and targeted interventions due to anticipated changes in the wellness of the individual. Collected factor data that directly characterizes the health of individuals is used to generate wellness scores characterizing the individual over time. The generated wellness scores are evaluated against contextual factors from the collected data to identify the contextual factors that, for the particular individual, are correlated to changes in individual wellness. The identified contextual factors and correlations form the individual's correlation trigger matrix.

Abstract: A system to assist users with the completion of tasks in a wellness program itinerary. The system assists users in completing tasks by recommending a controlled number of tasks for a user to perform in a next task period. The system determines the number of tasks to recommend by computing a pace that would enable the user to complete all wellness programs in the itinerary within a recommended time period. The system determines which tasks to recommend to the user based on several factors, such as a user state and user environment. The user environment is based on the location of the user, and may include the weather and surrounding landmarks at the location.

Abstract: A combination of a 4-anilino-3-cyanoquinoline compound (e.g. HKI-272, SKI-606, EKB-569) and a capecitabine compound in the treatment of a neoplasm is provided. Regimens, kits, and methods for treatment of neoplasm, including breast cancer including metastatic breast cancer, and lung cancer, using this combination, optionally in combination with other anti-neoplastic agents, or immune modulators are also described.

Abstract: A combination of a 4-anilino-3-cyanoquinoline compound (e.g. HKI-272, SKI-606, EKB-569) and a capecitabine compound in the treatment of a neoplasm is provided. Regimens, kits, and methods for treatment of neoplasm, including breast cancer including metastatic breast cancer, and lung cancer, using this combination, optionally in combination with other anti-neoplastic agents, or immune modulators are also described.

Abstract: A combination of a 4-anilino-3-cyanoquinoline compound (e.g. HKI-272, SKI-606, EKB-569) and a capecitabine compound in the treatment of a neoplasm is provided. Regimens, kits, and methods for treatment of neoplasm, including breast cancer including metastatic breast cancer, and lung cancer, using this combination, optionally in combination with other anti-neoplastic agents, or immune modulators are also described.

Abstract: A combination of a 4-anilino-3-cyanoquinoline compound (e.g. HKI-272, SKI-606, EKB-569) and a capecitabine compound in the treatment of a neoplasm is provided. Regimens, kits, and methods for treatment of neoplasm, including breast cancer including metastatic breast cancer, and lung cancer, using this combination, optionally in combination with other anti-neoplastic agents, or immune modulators are also described.

Abstract: The present invention relates to a novel Neospora caninum isolate from Nowra and extracts thereof. The strain is useful in the development of diagnostic assays for the detection of parasites in animals. The present invention also relates to pharmaceutical compositions, using live or killed organisms or extracts thereof, for the treatment and prevention of parasitic infections in animals.

Abstract: The present invention relates to polypeptides from N. caninum which are capable of raising an immune response when administered to an animal. Such polypeptides can be used in vaccination strategies for protecting animals, such as cows and dogs, from neosporosis.

Abstract: The present invention relates to a novel Neospora caninum isolate from Nowra and extracts thereof. The strain is useful in the development of diagnostic assays for the detection of parasites in animals. The present invention also relates to pharmaceutical compositions, using live or killed organisms or extracts thereof, for the treatment and prevention of parasitic infections in animals.